Literature DB >> 27722155

Prevention of Hepatocellular Carcinoma.

Kerstin Schütte1, Fathi Balbisi2, Peter Malfertheiner2.   

Abstract

The epidemiology of hepatocellular carcinoma (HCC) has significantly changed throughout the past decade and will continue to do so in the future as a consequence of effective primary prevention and treatment of virus-related liver diseases. However, other risk factors for HCC are constantly on the rise, including alcoholic liver disease and nonalcoholic fatty liver disease. The knowledge on these and further risk factors associated with an increased risk of HCC provide the opportunity and chance for the development and implementation of successful preventive strategies to decrease the worldwide burden of HCC. This mini-review gives a short overview on current strategies in primary, secondary, and tertiary prevention of HCC.

Entities:  

Keywords:  Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Prevention

Year:  2016        PMID: 27722155      PMCID: PMC5040884          DOI: 10.1159/000446680

Source DB:  PubMed          Journal:  Gastrointest Tumors        ISSN: 2296-3774


  57 in total

1.  Letter: can persisting liver stiffness indicate increased risk of HCC, after successful anti-HCV therapy?

Authors:  T Karlas; J Benckert; S Beer; V Keim; T Berg; J Wiegand
Journal:  Aliment Pharmacol Ther       Date:  2016-02       Impact factor: 8.171

Review 2.  Hepatitis B vaccination and prevention of hepatocellular carcinoma.

Authors:  Jia-Horng Kao
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-09-11       Impact factor: 3.043

3.  Does chemotherapy prevent HBV-related hepatocellular carcinoma? Pros.

Authors:  Yun-Fan Liaw
Journal:  Dig Liver Dis       Date:  2010-07       Impact factor: 4.088

4.  Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in west Africa: a community-based intervention study.

Authors:  P C Turner; A Sylla; Y Y Gong; M S Diallo; A E Sutcliffe; A J Hall; C P Wild
Journal:  Lancet       Date:  2005 Jun 4-10       Impact factor: 79.321

5.  Hepatitis B virus and cancer prevention.

Authors:  Mei-Hwei Chang
Journal:  Recent Results Cancer Res       Date:  2011

Review 6.  Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.

Authors:  Shoji Kubo; Shigekazu Takemura; Shogo Tanaka; Hiroji Shinkawa; Takayoshi Nishioka; Akinori Nozawa; Masahiko Kinoshita; Genya Hamano; Tokuji Ito; Yorihisa Urata
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

Review 7.  A cohesive European policy for hepatitis B vaccination, are we there yet?

Authors:  T Lernout; G Hendrickx; A Vorsters; L Mosina; N Emiroglu; P Van Damme
Journal:  Clin Microbiol Infect       Date:  2014-01-19       Impact factor: 8.067

Review 8.  How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the current literature.

Authors:  Gawain A Heckley; Johan Jarl; Benedict O Asamoah; Ulf G-Gerdtham
Journal:  BMC Cancer       Date:  2011-10-13       Impact factor: 4.430

9.  Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians.

Authors:  Pauline Arends; Milan J Sonneveld; Roeland Zoutendijk; Ivana Carey; Ashley Brown; Massimo Fasano; David Mutimer; Katja Deterding; Jurriën G P Reijnders; Ye Oo; Jörg Petersen; Florian van Bömmel; Robert J de Knegt; Teresa Santantonio; Thomas Berg; Tania M Welzel; Heiner Wedemeyer; Maria Buti; Pierre Pradat; Fabien Zoulim; Bettina Hansen; Harry L A Janssen
Journal:  Gut       Date:  2014-07-10       Impact factor: 23.059

10.  Early View of the Effectiveness of New Direct-Acting Antiviral (DAA) Regimens in Patients with Hepatitis C Virus (HCV).

Authors:  David R Walker; Marcos C Pedrosa; Shivaji R Manthena; Nikil Patel; Steven E Marx
Journal:  Adv Ther       Date:  2015-11-04       Impact factor: 3.845

View more
  7 in total

Review 1.  Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Authors:  Giacomo Emanuele Maria Rizzo; Giuseppe Cabibbo; Antonio Craxì
Journal:  Viruses       Date:  2022-05-07       Impact factor: 5.818

Review 2.  18F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular Carcinoma.

Authors:  Arno Kornberg; Martina Schernhammer; Helmut Friess
Journal:  J Clin Transl Hepatol       Date:  2017-07-08

3.  Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma.

Authors:  Bao-Min Shi; Wen Lu; Kun Ji; Yu-Feng Wang; Shuai Xiao; Xiu-Yan Wang
Journal:  World J Gastroenterol       Date:  2017-05-28       Impact factor: 5.742

4.  Disrupting Mitochondrial Pyruvate Uptake Directs Glutamine into the TCA Cycle away from Glutathione Synthesis and Impairs Hepatocellular Tumorigenesis.

Authors:  Sean C Tompkins; Ryan D Sheldon; Adam J Rauckhorst; Maria F Noterman; Shane R Solst; Jane L Buchanan; Kranti A Mapuskar; Alvin D Pewa; Lawrence R Gray; Lalita Oonthonpan; Arpit Sharma; Diego A Scerbo; Adam J Dupuy; Douglas R Spitz; Eric B Taylor
Journal:  Cell Rep       Date:  2019-09-03       Impact factor: 9.423

5.  Does access to care play a role in liver cancer survival? The ten-year (2006-2015) experience from a population-based cancer registry in Southern Italy.

Authors:  Walter Mazzucco; Francesco Vitale; Sergio Mazzola; Rosalba Amodio; Maurizio Zarcone; Davide Alba; Claudia Marotta; Rosanna Cusimano; Claudia Allemani
Journal:  BMC Cancer       Date:  2021-03-24       Impact factor: 4.430

6.  Biological Evaluation of [18F]AlF-NOTA-NSC-GLU as a Positron Emission Tomography Tracer for Hepatocellular Carcinoma.

Authors:  Liping Lin; Xianhong Xiang; Shu Su; Shaoyu Liu; Ying Xiong; Hui Ma; Gongjun Yuan; Dahong Nie; Ganghua Tang
Journal:  Front Chem       Date:  2021-04-16       Impact factor: 5.221

7.  Combining 18F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinoma.

Authors:  Arno Kornberg; Ulrike Witt; Martina Schernhammer; Jennifer Kornberg; Gueralp O Ceyhan; Katharina Mueller; Helmut Friess; Katharina Thrum
Journal:  Sci Rep       Date:  2017-10-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.